OKYO (OKYO Pharma Limited Ordinary Shares) Stock Analysis - AI Report

OKYO Pharma Limited Ordinary Shares (OKYO) is a publicly traded Healthcare sector company. As of May 19, 2026, OKYO trades at $1.59 with a market cap of $82.39M and a P/E ratio of 0.00. OKYO moved +0.00% today. Year to date, OKYO is -28.70%; over the trailing twelve months it is +7.43%. Its 52-week range spans $0.90 to $3.35. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces OKYO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on OKYO?

Rallies AI research for OKYO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

OKYO Key Metrics

Key financial metrics for OKYO
MetricValue
Price$1.59
Market Cap$82.39M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$3.35
52-Week Low$0.90
Volume11.05K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest OKYO News

Recent OKYO Insider Trades

  • BRANCACCIO JOHN P bought 16.67K (~$25.00K) on Sep 15, 2023.
  • CERRONE GABRIELE M bought 5.80M (~$440.80K) on May 19, 2022.
  • JACOB GARY S bought 12.50K (~$50.00K) on May 19, 2022.

OKYO Analyst Consensus

1 analysts cover OKYO: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.00.

Common questions about OKYO

What is the AI research view on OKYO?
Rallies AI research for OKYO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for OKYO?
Rallies AI research for OKYO combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is OKYO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for OKYO. It does not provide personalized investment advice.
OKYO

OKYO